Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 3 of the last 4 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 9 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
PHARMACIE NIMAX from Grez-Doiceau, company number BE0882213317, closed financial year 2025 with a result of € 45,216 after tax. For that financial year PHARMACIE NIMAX recorded a gross margin of € 103,086 and equity of € -354,595. Compared with financial year 2024, the result moved from € 30,357 to € 45,216. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on October 29, 2026.
€ -354,595
▲ € 45,216 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 45,216
▲ 49% vs 2024
Profit after tax over the fiscal year.
€ 52,208
▲ 133% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -511,820.
People and assets in 2025
€ 26,673
▲ € 22,395 vs 2024
Of which on lease € 819.
Debts at end 2025
€ 117,477
▼ 19% vs 2024
€ 41,905 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 49,859
▲ 40% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 21,387
▲ 113% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 24,000 | - | - | - | |
| Gross margin | - | € 86,717 | € 113,086 | € 103,086 | ▼ 9% |
| Profit after taxes | € 14,361 | € -795,668 | € 30,357 | € 45,216 | ▲ 49% |
| Equity | € 365,500 | € -430,168 | € -399,811 | € -354,595 | ▲ € 45,216 |
| Total debts | € 1,127,604 | € 970,927 | € 1,324,215 | € 1,370,644 | ▲ 4% |
| Cash | € 6,912 | € 46,921 | € 22,404 | € 52,208 | ▲ 133% |
| Land & buildings | € 313,271 | € 368,713 | € 645,482 | € 679,342 | ▲ 5% |
| Retained profit | € 208,276 | € -587,392 | € -557,035 | € -511,820 | ▲ € 45,216 |
| Bank debt | € 120,861 | € 87,782 | € 145,831 | € 117,477 | ▼ 19% |
| Balance sheet total | € 1,518,104 | € 565,759 | € 949,404 | € 1,041,049 | ▲ 10% |
By gross margin, PHARMACIE NIMAX ranks 2nd of 5 companies with main activity “Diverse ondersteunende activiteiten ten behoeve van voorzieningen” in Grez-Doiceau that publish figures (fiscal year 2025).
Key figures of PHARMACIE NIMAX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about PHARMACIE NIMAX the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to PHARMACIE NIMAX?
What happened at PHARMACIE NIMAX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 45,216 (▲ 49% vs 2024). filed late Source: NBB ↗
- Capital increase of € 248,702, published in the Gazette. Source: Staatsblad ↗
- Claude NIMAX became a director. NBB
- New establishment in Grez-Doiceau. KBO
- Carine GRZYBOWSKI became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 14,361 profit in 2022 to € 45,216 profit in 2025.
Paid € 33,988 in corporate taxes since 2022.
Best year ever: 2025, with € 45,216 profit.
Management
Behind PHARMACIE NIMAX are Carine GRZYBOWSKI and Claude NIMAX.
Directors
According to the 2025 annual accounts
Carine GRZYBOWSKI
Director
since 2006
Claude NIMAX
Director
since 2016
Establishments
Establishment units
Physical locations of this company
Rue de Hamme-Mille 28
1390 Grez-Doiceau
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Grez-Doiceau
Same main activity (Diverse ondersteunende activiteiten ten behoeve van voorzieningen), 4 active companies in Grez-Doiceau, largest first.
€ 104,635 gross margin · 2025
SOCIETE IMMOBILIERE DU VEVROUX
€ 47,997 gross margin · 2025
€ 19,308 gross margin · 2025
€ 4,914 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Capital increase
Source: Deed ↗- SA ALPHAR PARTNERS(inbrenger van schuldvorderingen (apport en nature bij kapitaalverhoging)) 58%
Details
- Company number
- 0882.213.317
- VAT number
- BE 0882.213.317
- Registered office
- Rue de Hamme-Mille 28, 1390 Grez-Doiceau
- Names & denominations
- PHARMACIE NIMAX
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 28 June 2006
- Peppol
- Active · Active since 25 Nov 2025
- Activities · NACE
Diverse ondersteunende activiteiten ten behoeve van voorzieningen
Beheer van overig onroerend goed
Overige zakelijke dienstverlening, neg
Overige zakelijke dienstverlening, n.e.g.